MONTELUKAST 10mg. IP + LEVOCITRIZINE 5mg. IP + AMBROXOL 75mg. IP

A combination of anti-asthma and anti-allergic drugs prevents asthma and relieves symptoms like sneezing, runny nose, and allergic skin due to various allergies. Has a rapid onset of action which relieves allergy symptoms like runny nose, watery eyes, and sneezing. Has better efficacy than desloratadine, loratadine, or fexofenadine in the management of allergic rhinitis and skin allergies. (NB Dhanya, 2008) Produces a significant decrease in sneezing, rhinorrhea, itching nose, itching eyes, and nasal congestion. (E Nettis, 2009) Induces a more substantial reduction of histamine wheal in a higher percentage of patients for a longer time than desloratadine. (E Nettis, 2009) An effective drug for treating chronic asthma reduces inflammation in the airways and nose and improves symptoms. Promotes mucous clearance facilitates expectoration and eases productive cough. (Mario Malerba, 2008) Produces clinically relevant improvements in asthma-related parameters, including symptoms, lung function parameters, quality of life, and the number of asthma exacerbations. (Zuzana Diamant, 2009) An effective prophylactic agent for asthma and relieves symptoms of seasonal allergies. Has a dual mechanism of action and acts both as a bronchodilator and anti-inflammatory agent. (Mohini Sachin Mahatme, 2016) Decreases the sputum's thickness, making it easier to cough out. An efficacious secretolytic therapy for patients with acute and chronic respiratory diseases. (Ahmad Kantar, 2020)